Koers GSRX Industries Inc. Other OTC
Aandelen
GSRX
US36255V1070
Farmaceutische producten
Omzet 2018 | 2,68 2,48 | Omzet 2019 | 11 10,16 | Marktkapitalisatie | 1,34 mln. 1,24 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | -16 mln. -14,78 mln. | Nettowinst (verlies) 2019 | -36 mln. -33,25 mln. | EV/omzet 2018 | 26.486.381 x |
Nettoliquiditeiten 2018 | 1,31 mln. 1,21 mln. | Nettoschuld 2019 | 2,27 mln. 2,1 mln. | EV/omzet 2019 | 328.290 x |
K/w-verhouding 2018 |
-4,29
x | K/w-verhouding 2019 |
-0,03
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 13,26% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Troy Nihart
CEO | Chief Executive Officer | 46 | 10-03-20 |
Director of Finance/CFO | 63 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Troy Nihart
CEO | Chief Executive Officer | 46 | 10-03-20 |
Jeff Rogers
BRD | Director/Board Member | 61 | 10-03-20 |
Shaun Dale
BRD | Director/Board Member | 47 | 23-04-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,78% | 723 mld. | |
+30,48% | 598 mld. | |
-3,51% | 364 mld. | |
+19,94% | 331 mld. | |
+5,14% | 288 mld. | |
+16,02% | 244 mld. | |
+9,85% | 210 mld. | |
-4,91% | 208 mld. | |
+9,32% | 169 mld. |